Exact Mass: 434.2416744
Exact Mass Matches: 434.2416744
Found 500 metabolites which its exact mass value is equals to given mass value 434.2416744
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Glutathionylspermidine
C17H34N6O5S (434.23112740000005)
The spermidine amide of glutathione.
Lexibulin
C24H30N6O2 (434.24301199999996)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
LysoPA(0:0/18:2(9Z,12Z))
LysoPA(0:0/18:2(9Z,12Z)) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).
LysoPA(18:2(9Z,12Z)/0:0)
LPA(18:2(9Z,12Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293) [HMDB] LysoPA(18:2(9Z,12Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).
(2s)-2-[[(2s)-2-Acetamido-5-[[n-(Methylcarbamoyl)carbamimidoyl]amino]pentanoyl]-Methyl-Amino]-3-Phenyl-Propanoic Acid
11-(Dansylamino)undecanoic acid
C23H34N2O4S (434.22391640000006)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003619 - Dansyl Compounds D004396 - Coloring Agents > D005456 - Fluorescent Dyes
Lexibulin
C24H30N6O2 (434.24301199999996)
Ribociclib
C23H30N8O (434.25424499999997)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Lophanthoidin F
DAUDA
C23H34N2O4S (434.22391640000006)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003619 - Dansyl Compounds D004396 - Coloring Agents > D005456 - Fluorescent Dyes
methyl 2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate
6-[(3E,6E)-2,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-3,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one
(all-Z)-5,7-dihydroxy-2-nonadeca-4,7,10,13,16-pentenyl-chromone|5,7-dihydroxy-2-((4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaen-1-yl)-4H-chromen-4-one|5,7-dihydroxy-2-((4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaenyl)-4H-chromen-4-one|5,7-dihydroxy-2-(4Z,7Z,10Z,13Z,16Z-nonadecapentaenyl)chromone
3-acetyleriocasin C|3beta,19-diacetoxy-6beta-hydroxy-7,16-dioxo-ent-abieta-15(17)-ene
3beta,19-diacetoxy-7alpha,14beta-dihydroxy-ent-kaur-16-en-15-one|pharicinin C
1alpha-(beta-D-glucopyranosyloxy)eudesma-3alpha,4beta,11-triol
2-Benzoyl-3,5-dihydroxy-4,4,6-tris(3-methyl-2-butenyl)-2,5-cyclohexadien-1-one
3alpha-hydroxy-2alpha-succinyloxy-labda-3,13-dien-15,16-olide
1alpha-Hydroxy-6-O-isobutyryl-3beta-(2-methylbutyryloxy)steiractinolid
17-hydroxy-7beta-succinyloxy-ent-cleroda-3,13-dien-15,16-olide
16-(4,9-dihydro-3H-beta-carbolin-1-yl)-17-nor-coryn-19-ene|3,4-Dihydro-usambarensin
2alpha,10alpha-diacetoxy-7,8,18,19-diepoxydolabell-3(E)-en-14-one
6alpha,17alpha-dihydroxy-15,17-oxidospongian-16-one 6,17-diacetate
(1R*,4S*,4aR*.6S*)-6-acetoxy-4-((5R)-5-acetoxy-1-methylenehexyl)-1-(3-methylbut-2-enyl)-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-3-one|(1R*,4S*,4aR*.6S*)-6-acetoxy-4-<(5R)-5-acetoxy-1-methylenehexyl>-1-(3-methylbut-2-enyl)-4,4a,5,6-tetrahydro-1H,3H-pyrano<3,4-c>pyran-3-one
(1RS,5RS,7RS)-3-benzoyl-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione|garciniaphenone
(10R,6E)-7,11-dimethyl-3-methylene-6-dodecaene-1,2,10,11-tetraol 10-O-beta-D-glucopyranoside|trikamsesquiside A
7-epi-uprolide-C diacetate|Di-Ac-(1S,3R,4R,7S,12S,13R,14R)-3,4-Epoxy-7,13-dihyroxy-8(19),15(17)-cembradien-16,14-olide
14alpha,17-diacetoxymulin-12-ene-11-one-20-oic acid|mulinone a
12alpha,14beta-dihydroxy-7alpha,18-diacetoxy-ent-kaur-16-en-15-one|wikstroemioidin G
11alpha,17-diacetoxymulin-12-en-14-one-20-oic acid|mulinone b
6,19-Di-Ac-2,6,19-Trihydroxy-8,13-labdadien-15,16-olide
3beta,11beta-diacetoxy-2beta,6alpha-dihydroxy-ent-kaur-16-en-15-one|taibairubescensin B
3beta,11beta-dihydroxy-6alpha,7beta-diacetoxy-ent-kaur-16-en-15-one|xindongnin C
Rosthornin B
6beta,19-diacetoxy-1alpha,15beta-dihydroxy-ent-kaur-16-en-7-one|maoesin E
13-oxo-7-[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxytetradecanoic acid
6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one
C24H34O7_{(1R,4aR,5S,6R,8S,8aR)-8-Acetoxy-5,6-dimethyl-5-[(2S,3aS,6aS)-2,3,3a,6a-tetrahydrofuro[2,3-b]furan-2-yl]octahydro-8aH-spiro[naphthalene-1,2-oxiran]-8a-yl}methyl acetate
6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based: Match]
6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based on: CCMSLIB00000847678]
6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based on: CCMSLIB00000847677]
Ala Phe Val Val
Ala Ile Met Thr
C18H34N4O6S (434.21989440000004)
Ala Ile Thr Met
C18H34N4O6S (434.21989440000004)
Ala Leu Met Thr
C18H34N4O6S (434.21989440000004)
Ala Leu Thr Met
C18H34N4O6S (434.21989440000004)
Ala Met Ile Thr
C18H34N4O6S (434.21989440000004)
Ala Met Leu Thr
C18H34N4O6S (434.21989440000004)
Ala Met Thr Ile
C18H34N4O6S (434.21989440000004)
Ala Met Thr Leu
C18H34N4O6S (434.21989440000004)
Ala Thr Ile Met
C18H34N4O6S (434.21989440000004)
Ala Thr Leu Met
C18H34N4O6S (434.21989440000004)
Ala Thr Met Ile
C18H34N4O6S (434.21989440000004)
Ala Thr Met Leu
C18H34N4O6S (434.21989440000004)
Ala Val Phe Val
Ala Val Val Phe
Cys Gly Lys Lys
C17H34N6O5S (434.23112740000005)
Cys Ile Ile Ser
C18H34N4O6S (434.21989440000004)
Cys Ile Leu Ser
C18H34N4O6S (434.21989440000004)
Cys Ile Ser Ile
C18H34N4O6S (434.21989440000004)
Cys Ile Ser Leu
C18H34N4O6S (434.21989440000004)
Cys Ile Thr Val
C18H34N4O6S (434.21989440000004)
Cys Ile Val Thr
C18H34N4O6S (434.21989440000004)
Cys Lys Gly Lys
C17H34N6O5S (434.23112740000005)
Cys Lys Lys Gly
C17H34N6O5S (434.23112740000005)
Cys Leu Ile Ser
C18H34N4O6S (434.21989440000004)
Cys Leu Leu Ser
C18H34N4O6S (434.21989440000004)
Cys Leu Ser Ile
C18H34N4O6S (434.21989440000004)
Cys Leu Ser Leu
C18H34N4O6S (434.21989440000004)
Cys Leu Thr Val
C18H34N4O6S (434.21989440000004)
Cys Leu Val Thr
C18H34N4O6S (434.21989440000004)
Cys Ser Ile Ile
C18H34N4O6S (434.21989440000004)
Cys Ser Ile Leu
C18H34N4O6S (434.21989440000004)
Cys Ser Leu Ile
C18H34N4O6S (434.21989440000004)
Cys Ser Leu Leu
C18H34N4O6S (434.21989440000004)
Cys Thr Ile Val
C18H34N4O6S (434.21989440000004)
Cys Thr Leu Val
C18H34N4O6S (434.21989440000004)
Cys Thr Val Ile
C18H34N4O6S (434.21989440000004)
Cys Thr Val Leu
C18H34N4O6S (434.21989440000004)
Cys Val Ile Thr
C18H34N4O6S (434.21989440000004)
Cys Val Leu Thr
C18H34N4O6S (434.21989440000004)
Cys Val Thr Ile
C18H34N4O6S (434.21989440000004)
Cys Val Thr Leu
C18H34N4O6S (434.21989440000004)
Phe Ala Val Val
Phe Gly Ile Val
Phe Gly Leu Val
Phe Gly Val Ile
Phe Gly Val Leu
Phe Ile Gly Val
Phe Ile Val Gly
Phe Leu Gly Val
Phe Leu Val Gly
Phe Val Ala Val
Phe Val Gly Ile
Phe Val Gly Leu
Phe Val Ile Gly
Phe Val Leu Gly
Phe Val Val Ala
Gly Cys Lys Lys
C17H34N6O5S (434.23112740000005)
Gly Phe Ile Val
Gly Phe Leu Val
Gly Phe Val Ile
Gly Phe Val Leu
Gly Ile Phe Val
Gly Ile Val Phe
Gly Lys Cys Lys
C17H34N6O5S (434.23112740000005)
Gly Lys Lys Cys
C17H34N6O5S (434.23112740000005)
Gly Leu Phe Val
Gly Leu Val Phe
Gly Val Phe Ile
Gly Val Phe Leu
Gly Val Ile Phe
Gly Val Leu Phe
Ile Ala Met Thr
C18H34N4O6S (434.21989440000004)
Ile Ala Thr Met
C18H34N4O6S (434.21989440000004)
Ile Cys Ile Ser
C18H34N4O6S (434.21989440000004)
Ile Cys Leu Ser
C18H34N4O6S (434.21989440000004)
Ile Cys Ser Ile
C18H34N4O6S (434.21989440000004)
Ile Cys Ser Leu
C18H34N4O6S (434.21989440000004)
Ile Cys Thr Val
C18H34N4O6S (434.21989440000004)
Ile Cys Val Thr
C18H34N4O6S (434.21989440000004)
Ile Phe Gly Val
Ile Phe Val Gly
Ile Gly Phe Val
Ile Gly Val Phe
Ile Ile Cys Ser
C18H34N4O6S (434.21989440000004)
Ile Ile Ser Cys
C18H34N4O6S (434.21989440000004)
Ile Leu Cys Ser
C18H34N4O6S (434.21989440000004)
Ile Leu Ser Cys
C18H34N4O6S (434.21989440000004)
Ile Met Ala Thr
C18H34N4O6S (434.21989440000004)
Ile Met Thr Ala
C18H34N4O6S (434.21989440000004)
Ile Ser Cys Ile
C18H34N4O6S (434.21989440000004)
Ile Ser Cys Leu
C18H34N4O6S (434.21989440000004)
Ile Ser Ile Cys
C18H34N4O6S (434.21989440000004)
Ile Ser Leu Cys
C18H34N4O6S (434.21989440000004)
Ile Thr Ala Met
C18H34N4O6S (434.21989440000004)
Ile Thr Cys Val
C18H34N4O6S (434.21989440000004)
Ile Thr Met Ala
C18H34N4O6S (434.21989440000004)
Ile Thr Thr Thr
Ile Thr Val Cys
C18H34N4O6S (434.21989440000004)
Ile Val Cys Thr
C18H34N4O6S (434.21989440000004)
Ile Val Phe Gly
Ile Val Gly Phe
Ile Val Thr Cys
C18H34N4O6S (434.21989440000004)
Lys Cys Gly Lys
C17H34N6O5S (434.23112740000005)
Lys Cys Lys Gly
C17H34N6O5S (434.23112740000005)
Lys Gly Cys Lys
C17H34N6O5S (434.23112740000005)
Lys Gly Lys Cys
C17H34N6O5S (434.23112740000005)
Lys Lys Cys Gly
C17H34N6O5S (434.23112740000005)
Lys Lys Gly Cys
C17H34N6O5S (434.23112740000005)
Leu Ala Met Thr
C18H34N4O6S (434.21989440000004)
Leu Ala Thr Met
C18H34N4O6S (434.21989440000004)
Leu Cys Ile Ser
C18H34N4O6S (434.21989440000004)
Leu Cys Leu Ser
C18H34N4O6S (434.21989440000004)
Leu Cys Ser Ile
C18H34N4O6S (434.21989440000004)
Leu Cys Ser Leu
C18H34N4O6S (434.21989440000004)
Leu Cys Thr Val
C18H34N4O6S (434.21989440000004)
Leu Cys Val Thr
C18H34N4O6S (434.21989440000004)
Leu Phe Gly Val
Leu Phe Val Gly
Leu Gly Phe Val
Leu Gly Val Phe
Leu Ile Cys Ser
C18H34N4O6S (434.21989440000004)
Leu Ile Ser Cys
C18H34N4O6S (434.21989440000004)
Leu Leu Cys Ser
C18H34N4O6S (434.21989440000004)
Leu Leu Ser Cys
C18H34N4O6S (434.21989440000004)
Leu Met Ala Thr
C18H34N4O6S (434.21989440000004)
Leu Met Thr Ala
C18H34N4O6S (434.21989440000004)
Leu Ser Cys Ile
C18H34N4O6S (434.21989440000004)
Leu Ser Cys Leu
C18H34N4O6S (434.21989440000004)
Leu Ser Ile Cys
C18H34N4O6S (434.21989440000004)
Leu Ser Leu Cys
C18H34N4O6S (434.21989440000004)
Leu Thr Ala Met
C18H34N4O6S (434.21989440000004)
Leu Thr Cys Val
C18H34N4O6S (434.21989440000004)
Leu Thr Met Ala
C18H34N4O6S (434.21989440000004)
Leu Thr Thr Thr
Leu Thr Val Cys
C18H34N4O6S (434.21989440000004)
Leu Val Cys Thr
C18H34N4O6S (434.21989440000004)
Leu Val Phe Gly
Leu Val Gly Phe
Leu Val Thr Cys
C18H34N4O6S (434.21989440000004)
Met Ala Ile Thr
C18H34N4O6S (434.21989440000004)
Met Ala Leu Thr
C18H34N4O6S (434.21989440000004)
Met Ala Thr Ile
C18H34N4O6S (434.21989440000004)
Met Ala Thr Leu
C18H34N4O6S (434.21989440000004)
Met Ile Ala Thr
C18H34N4O6S (434.21989440000004)
Met Ile Thr Ala
C18H34N4O6S (434.21989440000004)
Met Leu Ala Thr
C18H34N4O6S (434.21989440000004)
Met Leu Thr Ala
C18H34N4O6S (434.21989440000004)
Met Ser Val Val
C18H34N4O6S (434.21989440000004)
Met Thr Ala Ile
C18H34N4O6S (434.21989440000004)
Met Thr Ala Leu
C18H34N4O6S (434.21989440000004)
Met Thr Ile Ala
C18H34N4O6S (434.21989440000004)
Met Thr Leu Ala
C18H34N4O6S (434.21989440000004)
Met Val Ser Val
C18H34N4O6S (434.21989440000004)
Met Val Val Ser
C18H34N4O6S (434.21989440000004)
Ser Cys Ile Ile
C18H34N4O6S (434.21989440000004)
Ser Cys Ile Leu
C18H34N4O6S (434.21989440000004)
Ser Cys Leu Ile
C18H34N4O6S (434.21989440000004)
Ser Cys Leu Leu
C18H34N4O6S (434.21989440000004)
Ser Ile Cys Ile
C18H34N4O6S (434.21989440000004)
Ser Ile Cys Leu
C18H34N4O6S (434.21989440000004)
Ser Ile Ile Cys
C18H34N4O6S (434.21989440000004)
Ser Ile Leu Cys
C18H34N4O6S (434.21989440000004)
Ser Leu Cys Ile
C18H34N4O6S (434.21989440000004)
Ser Leu Cys Leu
C18H34N4O6S (434.21989440000004)
Ser Leu Ile Cys
C18H34N4O6S (434.21989440000004)
Ser Leu Leu Cys
C18H34N4O6S (434.21989440000004)
Ser Met Val Val
C18H34N4O6S (434.21989440000004)
Ser Val Met Val
C18H34N4O6S (434.21989440000004)
Ser Val Val Met
C18H34N4O6S (434.21989440000004)
Thr Ala Ile Met
C18H34N4O6S (434.21989440000004)
Thr Ala Leu Met
C18H34N4O6S (434.21989440000004)
Thr Ala Met Ile
C18H34N4O6S (434.21989440000004)
Thr Ala Met Leu
C18H34N4O6S (434.21989440000004)
Thr Cys Ile Val
C18H34N4O6S (434.21989440000004)
Thr Cys Leu Val
C18H34N4O6S (434.21989440000004)
Thr Cys Val Ile
C18H34N4O6S (434.21989440000004)
Thr Cys Val Leu
C18H34N4O6S (434.21989440000004)
Thr Ile Ala Met
C18H34N4O6S (434.21989440000004)
Thr Ile Cys Val
C18H34N4O6S (434.21989440000004)
Thr Ile Met Ala
C18H34N4O6S (434.21989440000004)
Thr Ile Thr Thr
Thr Ile Val Cys
C18H34N4O6S (434.21989440000004)
Thr Leu Ala Met
C18H34N4O6S (434.21989440000004)
Thr Leu Cys Val
C18H34N4O6S (434.21989440000004)
Thr Leu Met Ala
C18H34N4O6S (434.21989440000004)
Thr Leu Thr Thr
Thr Leu Val Cys
C18H34N4O6S (434.21989440000004)
Thr Met Ala Ile
C18H34N4O6S (434.21989440000004)
Thr Met Ala Leu
C18H34N4O6S (434.21989440000004)
Thr Met Ile Ala
C18H34N4O6S (434.21989440000004)
Thr Met Leu Ala
C18H34N4O6S (434.21989440000004)
Thr Thr Ile Thr
Thr Thr Leu Thr
Thr Thr Thr Ile
Thr Thr Thr Leu
Thr Val Cys Ile
C18H34N4O6S (434.21989440000004)
Thr Val Cys Leu
C18H34N4O6S (434.21989440000004)
Thr Val Ile Cys
C18H34N4O6S (434.21989440000004)
Thr Val Leu Cys
C18H34N4O6S (434.21989440000004)
Val Ala Phe Val
Val Ala Val Phe
Val Cys Ile Thr
C18H34N4O6S (434.21989440000004)
Val Cys Leu Thr
C18H34N4O6S (434.21989440000004)
Val Cys Thr Ile
C18H34N4O6S (434.21989440000004)
Val Cys Thr Leu
C18H34N4O6S (434.21989440000004)
Val Phe Ala Val
Val Phe Gly Ile
Val Phe Gly Leu
Val Phe Ile Gly
Val Phe Leu Gly
Val Phe Val Ala
Val Gly Phe Ile
Val Gly Phe Leu
Val Gly Ile Phe
Val Gly Leu Phe
Val Ile Cys Thr
C18H34N4O6S (434.21989440000004)
Val Ile Phe Gly
Val Ile Gly Phe
Val Ile Thr Cys
C18H34N4O6S (434.21989440000004)
Val Leu Cys Thr
C18H34N4O6S (434.21989440000004)
Val Leu Phe Gly
Val Leu Gly Phe
Val Leu Thr Cys
C18H34N4O6S (434.21989440000004)
Val Met Ser Val
C18H34N4O6S (434.21989440000004)
Val Met Val Ser
C18H34N4O6S (434.21989440000004)
Val Ser Met Val
C18H34N4O6S (434.21989440000004)
Val Ser Val Met
C18H34N4O6S (434.21989440000004)
Val Thr Cys Ile
C18H34N4O6S (434.21989440000004)
Val Thr Cys Leu
C18H34N4O6S (434.21989440000004)
Val Thr Ile Cys
C18H34N4O6S (434.21989440000004)
Val Thr Leu Cys
C18H34N4O6S (434.21989440000004)
Val Val Ala Phe
Val Val Phe Ala
Val Val Met Ser
C18H34N4O6S (434.21989440000004)
Val Val Ser Met
C18H34N4O6S (434.21989440000004)
(R)-1-BOC-4-(3-CBZ-AMINO-3-METHOXYCARBONYL-PROPYL)PIPERIDINE
1-N,4-N-bis(2-methylphenyl)-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide
C24H30N6O2 (434.24301199999996)
methyl 2-[[(2E)-2-benzylideneoctylidene]amino]benzoate
butyl 2-methylprop-2-enoate,4-hydroxy-2-methylidenebutanoic acid,prop-2-enoic acid,styrene
5-CHLORO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE
sodium 2-[2-[2-(tridecyloxy)ethoxy]ethoxy]ethyl sulphate
2-[2-(2,3-dihydro-5-methoxy-2,3,3-trimethyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium acetate
4-CHLORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE
Acrylic acid, butyl acrylate, 2-hydroxyethyl methacrylate, styrene polymer
1-N,4-N-bis(3-methylphenyl)-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide
C24H30N6O2 (434.24301199999996)
(2-(7-(2-(4-Cyano-2-fluorophenoxy)ethyl)-9-oxa-3,7-diazabicyclo(3.3.1)non-3-yl)ethyl)carbamic acid tert-butyl ester
Ribociclib
C23H30N8O (434.25424499999997)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
(2S)-2-amino-5-[[(2R)-1-[[2-[4-(3-aminopropylamino)butylamino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid
C17H34N6O5S (434.23112740000005)
[3,9-Dicarboxy-2,10-dihydroxy-5-methyl-4,8-dioxo-11-(trimethylazaniumyl)undecyl]-trimethylazanium
3-acetyleriocasin C, (rel)-
A natural product found in Isodon eriocalyx.
N-[2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-5-oxazolecarboxamide
C25H30N4O3 (434.23177899999996)
N-[2-(cyclopentylamino)-2-oxoethyl]-4,7-dimethyl-N-(2-methylphenyl)-2-oxo-3H-pyrido[1,2-a]pyrimidine-4-carboxamide
C25H30N4O3 (434.23177899999996)
(2E,4E,8S,10E,12Z)-1-[(3E,5S)-5-[(4-hydroxyphenyl)methyl]-2,4-dioxopyrrolidin-3-ylidene]-4,8-dimethyltetradeca-2,4,10,12-tetraen-1-olate
(2S)-2-[(4S,5R)-8-(2-cyclohexylethynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H34N2O4S (434.22391640000006)
(2R)-2-[(4S,5S)-8-(2-cyclohexylethynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H34N2O4S (434.22391640000006)
2-[(3R,6aS,8S,10aS)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3R,6aR,8S,10aR)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3S,6aS,8R,10aS)-1-(4-fluorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-piperidin-1-ylethanone
2-[(3S,6aR,8S,10aR)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-cyclopropyl-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-6-oxo-12-(2-phenylethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
(6S,7S,8S)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H30N4O3 (434.23177899999996)
(6R,7R,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H30N4O3 (434.23177899999996)
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(3-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
C25H30N4O3 (434.23177899999996)
[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-pyridinyl)methanone
C25H30N4O3 (434.23177899999996)
cyclohexyl-[(2S,3R)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone
cyclohexyl-[(2R,3R)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone
1-[(2S,3S)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
(2R)-2-[(4R,5R)-8-(2-cyclohexylethynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H34N2O4S (434.22391640000006)
(2S)-2-[(4R,5R)-8-(2-cyclohexylethynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H34N2O4S (434.22391640000006)
(2S)-2-[(4R,5S)-8-(2-cyclohexylethynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H34N2O4S (434.22391640000006)
2-cyclopropyl-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-[(3R,6aR,8R,10aR)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3S,6aS,8S,10aS)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
C25H30N4O3 (434.23177899999996)
(6S,7S,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H30N4O3 (434.23177899999996)
1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-(3-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
C25H30N4O3 (434.23177899999996)
cyclohexyl-[(2S,3S)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone
cyclohexyl-[(2R,3S)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone
[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-pyridinyl)methanone
C25H30N4O3 (434.23177899999996)
1-[(2R,3R)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
1-[(2S,3R)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
[(4E,8E)-2-acetamido-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(propanoylamino)dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(2,4,5-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-2-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one
13-Oxo-7-[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxytetradecanoic acid
1-Oleoylglycerone 3-phosphate
A 1-acylglycerone 3-phosphate in which the acyl group is specified as oleoyl.
lysophosphatidic acid 0:0/18:2(9Z,12Z)
A 2-acyl-sn-glycerol 3-phosphate having (9Z,12Z)-octadeca-9,12-dienoyl as the 2-O-acyl group.
1-linoleoyl-sn-glycerol 3-phosphate
A 1-acyl-sn-glycerol 3-phosphate having linoleyl (9Z,12Z-octadecadienoyl) as the 1-O-acyl group.
1-Oleoyl-sn-glycero-3-phosphate(2-)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleoyl-sn-glycero-3-phosphate.
1-stearoylglycerone 3-phosphate(2-)
A 1-acylglycerone 3-phosphate(2-) obtained by deprotonation of the phospho groups of 1-stearoylglycerone 3-phosphate; major species at pH 7.3.
2-Oleoyl-sn-glycero-3-phosphate(2-)
A 2-acyl-sn-glycero-3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 2-oleoyl-sn-glycero-3-phosphate; major species at pH 7.3.